GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (NYSE:MDT) » Definitions » Scaled Net Operating Assets

Medtronic (Medtronic) Scaled Net Operating Assets : 0.76 (As of Jan. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Medtronic Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medtronic's operating assets for the quarter that ended in Jan. 2024 was $82,515 Mil. Medtronic's operating liabilities for the quarter that ended in Jan. 2024 was $13,658 Mil. Medtronic's Total Assets for the quarter that ended in Oct. 2023 was $90,087 Mil. Therefore, Medtronic's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was 0.76.


Medtronic Scaled Net Operating Assets Historical Data

The historical data trend for Medtronic's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Scaled Net Operating Assets Chart

Medtronic Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.72 0.74 0.71 0.75

Medtronic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.72 0.75 0.76 0.76

Competitive Comparison of Medtronic's Scaled Net Operating Assets

For the Medical Devices subindustry, Medtronic's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Medtronic's Scaled Net Operating Assets falls into.



Medtronic Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Medtronic's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Apr. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Apr. 2023 )
=(Operating Assets (A: Apr. 2023 )-Operating Liabilities (A: Apr. 2023 ))/Total Assets (A: Apr. 2022 )
=(82989-14919)/90981
=0.75

where

Operating Assets(A: Apr. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90948 - 7959
=82989

Operating Liabilities(A: Apr. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=39283 - 24344 - 20
=14919

Medtronic's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2024 )
=(Operating Assets (Q: Jan. 2024 )-Operating Liabilities (Q: Jan. 2024 ))/Total Assets (Q: Oct. 2023 )
=(82515-13658)/90087
=0.76

where

Operating Assets(Q: Jan. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90836 - 8321
=82515

Operating Liabilities(Q: Jan. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=38840 - 24153 - 1029
=13658

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medtronic Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Medtronic's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic (Medtronic) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Executives
Brett A. Wall officer: EVP & Group Pres Restora Thera 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Gregory L Smith officer: EVP Global Ops & Supply Chain 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Michael Marinaro officer: EVP & President, Surgical OU 710 MEDTRONIC PARKWAY NE, LC300, MINNEAPOLIS MN 55432
Hoedt Rob Ten officer: EVP & President EMEAC 710 MEDTRONIC PKWY, MSLC300, MINNEAPOLIS MN 55432
Gregory P Lewis director C/O HONEYWELL INTERNATIONAL INC., 300 SOUTH TRYON STREET, CHARLOTTE NC 28202
Sean Salmon officer: EVP & Group President Diabetes MEDTRONIC PLC, 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Lidia Fonseca director 358 SOUTH MAIN STREET, BURLINGTON NC 27215
Karen L Parkhill officer: EVP & Chief Financial Officer 1717 MAIN STREET, MC 6402, DALLAS TX 75201
Ivan K Fong officer: EVP GENERAL COUNSEL & SECR 3M CENTER, ST. PAUL MN 55144-1000
Robert John White officer: EVP & President MITG MEDTRONIC PLC, 710 MEDTRONIC PKWY MS LC300, MINNEAPOLIS MN 55432
Richard H Anderson director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Bradley E Lerman officer: SVP General Counsel & Corp Sec MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Geoffrey Martha officer: Sr VP, Strategy & Bus Dev 710 MEDTRONIC PKWAY, MS LC300, MINNEAPOLIS MN 55432
Jennifer M Kirk officer: Chief Accounting Officer 5 GREENWAY PLAZA, SUITE 110, HOUSTON TX 77046
John R Liddicoat officer: EVP & President of Americas MEDTRONIC PLC, 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432

Medtronic (Medtronic) Headlines

From GuruFocus

Q2 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024

Medtronic PLC Investor Update Transcript

By GuruFocus Research 01-23-2024

Medtronic PLC at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Medtronic PLC Earnings Call Transcript

By GuruFocus Research 01-23-2024